financing

News

Spain's SpliceBio has raised $135m in financing that will help it move a gene-editing therapy for Stargardt disease through clinical testing.

News

In another sign of recovery in digital health investing, Omada Health has priced an IPO that could value the company at more than $1.1 billion.

News

Brain-computer interface firm Neuralink has completed a $650m financing that it says will help to "bring our technology to more people."

News

Our round-up of recent biotech financings includes rounds for GRIN Therapeutics, GlycoEra, Syndeio, Juvenescence, and Vima Therapeutics.

News

In a signal of a return to investor appetite for digital health stocks, Hinge Health has raised an impressive $437 million in an IPO.

News

Our round-up of recent biotech financings includes rounds for Pathos AI, Stylus Medicine, Haya Therapeutics, Therini Bio and Tiltbio.